CORT

Corcept Therapeutics Incorporated

28.08 USD
-0.01 (-0.04%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Corcept Therapeutics Incorporated stock is up 22.35% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 47.62% of the previous 20 May’s closed higher than April. In the last 10 Unusual Options Trades, there were 5 CALLs, 5 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
10 May 16:23 15 Nov, 2024 35.00 CALL 99 300
10 May 17:05 15 Nov, 2024 35.00 CALL 147 300
10 May 18:34 21 Jun, 2024 22.00 PUT 5000 5652
13 May 14:31 21 Jun, 2024 25.00 CALL 70 585
13 May 14:41 19 Jul, 2024 23.00 PUT 220 42
13 May 16:37 21 Jun, 2024 32.00 CALL 86 1896
14 May 15:15 17 May, 2024 25.00 CALL 100 1417
17 May 15:49 21 Jun, 2024 30.00 PUT 43 3
17 May 18:08 21 Jun, 2024 30.00 PUT 40 3
17 May 18:31 21 Jun, 2024 30.00 PUT 47 3

About Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the. treatment of hyperglycemia secondary to hypercortisolism in adult patients with. endogenous Cushing's syndrome.

  • HC Wainwright & Co.
    Thu May 2, 13:32
    buy
    confirm
  • Truist Securities
    Thu May 2, 09:12
    buy
    confirm
  • HC Wainwright & Co.
    Tue Apr 23, 13:27
    buy
    confirm